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ABSTRACT
Objective To determine whether steroids are effective in
preventing laryngeal oedema after extubation and
reducingtheneedforsubsequentreintubationincritically
ill adults.
Design Meta-analysis.
Data sources PubMed, Cochrane Controlled Trials
Register, Web of Science, and Embase with no limitation
on language, study year, or publication status.
SelectioncriteriaRandomisedplacebocontrolledtrialsin
whichparenteralsteroidswerecomparedwithplacebofor
preventing complications after extubation in adults.
Review methods Search, application of inclusion and
exclusion criteria, data extraction, and assessment of
methodological quality, independently performed in
duplicate.Oddsratioswith95%confidenceintervals,risk
difference, and number needed to treat were calculated
and pooled.
Main outcome measures Primary outcome: laryngeal
oedema after extubation. Secondary outcome:
subsequent reintubation because of laryngeal oedema.
ResultsSixtrials(n=1923)wereidentified.Comparedwith
placebo, steroids given before planned extubation
decreasedtheoddsratioforlaryngealoedema(0.38,95%
confidence interval 0.17 to 0.85) and subsequent
reintubation (0.29, 0.15 to 0.58), corresponding with a
risk difference of −0.10 (−0.12 to −0.07; number needed
to treat 10) and −0.02 (−0.04 to −0.01; 50), respectively.
Subgroupanalyses indicatedthata multidoseregimenof
steroidshad marked positiveeffectson the occurrenceof
laryngeal oedema (0.14; 0.08 to 0.23) and on the rate of
subsequent reintubation (0.19; 0.07 to 0.50), with a risk
differenceof−0.19(−0.24to−0.15;5)and−0.04(−0.07to
−0.02;25).Insingledosestherewasonlyatrendtowards
benefit, with the confidence interval including 1. Side
effects related to steroids were not found.
Conclusion Prophylactic administration of steroids in
multidose regimens before planned extubation reduces
the incidence of laryngeal oedema after extubation and
the consequent reintubation rate in adults, with few
adverse events.
INTRODUCTION
Critically ill patients and those undergoing surgery
routinelyundergoendotrachealintubationtofacilitate
mechanical ventilation in the intensive care unit and
operatingroom.
1Asthesepatientsrecover,respiratory
support is gradually reduced until the patient can
breathe unaided and the endotracheal tube can be
removed.Althoughextubationisgenerallyuneventful,
in some patients mechanical irritation by the endo-
tracheal tube causes substantial laryngeal oedema,
2
despiteuseofahighvolumeandlowpressurecuff
3w3or
laryngeal ultrasound monitoring.
4 Laryngeal oedema,
one of the most common complications, can result in
stridor and dyspnoea and need for reintubation.
3 Such
complications, particularly reintubation, might lead to
a prolonged stay in intensive care, additional costs,
potential morbidity, and mortality.
5 Any intervention
that increases the chances of successful extubation is
therefore of great interest.
To avoid airway complications, patients are often
givensteroidsbeforeextubation.Prophylacticsteroids
substantially reduce the incidence of stridor after
extubation in children and tend to decrease the rate
of reintubation and stridor in neonates,
6-9 but the
findings might not be applicable to adults because of
differences in anatomy of the upper airway and the
approach to airway management. The evidence to
support this approach in adults is therefore limited or
controversial
6710 because of the limited number of
randomised trials. Previous meta-analyses based on
trials in adults up to 2007 yielded inconclusive or
negative results and lack reliability because of small
sample sizes.
6-8 Furthermore, there have been no
subgroup analyses by sex or number of doses or in
high risk patients or examining the interval between
administration of steroids and extubation.
w4 w5
We carried out an updated meta-analysis to deter-
mine whether steroids are effective in preventing
laryngeal oedema after extubation in adults and
whethertheyreducetheneedforsubsequentreintuba-
tion and to examine any reported side effects.
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Search strategy and selection criteria
We searched electronic databases including PubMed
(1966 to June 2008), CENTRAL (Cochrane Con-
trolled Trials Register; issue 2, 2008), Web of Science
(1994 to June 2008), and Embase (1984 to June 2008),
adopting the search strategy combining the terms
“(anti-inflammatory agents OR glucocorticoid* OR
corticosteroid* OR steroid* OR dexamet* OR hydro-
cort* OR Predniso* OR beclomet* OR methylpredni-
solone) AND (intubation, intratracheal OR airway
obstruction OR laryngeal oedema OR stridor OR
extubation)” with the high sensitive searching filter
provided by the Cochrane Library.
11 We identified all
clinical trials on steroids and complications after
extubation and searched reference lists of review
articles and included studies to identify other poten-
tially eligible studies. There was no limitation on
language, year of publication, or publication status.
Trials were included if they were randomised
placebo controlled trials comparing the prophylactic
administration of steroids versus placebo before
plannedextubationinadults,withadequatelyreported
dataoneithertheoccurrenceoflaryngealoedemaafter
extubationortherateofconsequentreintubation.After
exclusion of duplicates, TF and GW reviewed the full
textofallcitationswithtitlesandabstractsthatseemed
to fit the criteria for inclusion. Citations that were
clearlynotrelevantorwerenotrandomisedcontrolled
trials were not reviewed in full. The numbers of
citations rejected and the reasons for rejection were
tracked.
Data extraction and quality assessment
From each article we extracted details of authors, year
of publication, geographical location of the study,
studypopulation,sex,samplesize,time constraintsfor
investigation after extubation, dropouts or withdra-
wals, interventions, outcomes, adverse events, and
intention to treat analysis.
The two reviewers independently assessed alloca-
tion concealment and likelihood of bias to determine
methodological quality of the included trials. The
allocation concealment was ranked as adequate,
uncertain, or clearly inadequate; and the likelihood of
biaswasscoredonaJadad5pointscale,whichcontains
twoquestionseachonrandomisationandmaskingand
one question on the reporting of dropouts and
withdrawals.
12 Any disagreement between reviewers
was resolved by consensus.
Primary and second outcomes
In intubated patients direct laryngoscopic visualisa-
tion, the ideal method for diagnosing laryngeal
oedema, requires movement of the endotracheal
tube, which might be unsafe in unstable critically ill
patients and thus is not routinely applied in clinical
practice. After extubation, stridor or dyspnoea—an
audible high pitched inspiratory wheeze caused by
turbulent airflow through narrowed airways—is gen-
erally accepted as a clinical indication of laryngeal
oedema.
w2 We therefore defined minor laryngeal
oedema as stridor and dyspnoea after extubation and
major laryngeal oedema as severe respiratory distress
resulting in tracheal reintubation secondary to upper
airwayobstruction.Ourprimaryoutcomeinthismeta-
analysis was laryngeal oedema after extubation, with
subsequent reintubation caused by laryngeal oedema
as the secondary outcome.
Statistical analysis
We treated our two outcomes as dichotomous vari-
ables and reported odds ratios with 95% confidence
intervals. We examined heterogeneity with the Q
statistic (P<0.1, considered significant). We used a
random effects model if the Q statistic was significant,
Duplicates excluded (n=180)
Not randomised controlled trials (n=15):
  Reviews (n=6)
  Comments (n=8)
  Animal (n=1)
Citations screened for titles and abstracts (n=1500)
Unique abstracts identified (n=1320)
Irrelevant trials excluded (n=1292)
Detailed information evaluated (n=28)
Studies on children or infants excluded  (n=7)
Eligible randomised controlled trials identified (n=6)
Randomised controlled trials included (n=13)
Fig 1 | Flow of study identification, inclusion, exclusion
Table 1 |Quality assessment of included randomised placebo controlled trials on parenteral steroids for preventing
complications in adults after extubation
Reference Double blinding Intention to treat Allocation concealment Jadad score (0-5) Adverse events
Gaussorgues 1987
w1 No No Uncertain 1 No
Darmon 1992
w2 Yes No Adequate 5 No
Ho 1996
w3 Yes No Adequate 4 No
Cheng 2006
w4 Yes No Adequate 4 Yes
Francois 2007
w5 Yes Yes Adequate 5 Yes
Lee 2007
w6 Yes No Adequate 5 Yes
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Steroids Placebo
Gaussorgues 1987
w1 (France and multicentre)
Study population Pneumonia, haemodynamic instability, postoperative, neurological
Time constraint* 48 hours
Mean (SD) age (years) 55 (26) 53 (23)
Sample size (% female) 138 (33.3) 138 (36.2)
Intervention in steroid group 40 mg IV and 40 mg IM methylprednisolone 30 min before
extubation
—
Laryngeal oedema 42
Reintubation 20
Darmon 1992
w2 (France and multicentre)
Study population Haemodynamic instability, neurological, postoperative
Time constraint* 24 hours
Mean (SD) age (years) 49 (18.8) intubated for <36 h; 55.4 (17.9)
intubated for >36 h
47.7 (19.4) intubated for <36 h; 59.4 (19.8)
intubated for >36 h
Sample size (% female) 348 (39.7) 352 (44.6)
Intervention in steroid group 8 mg IV dexamethasone 1 h before extubation —
Laryngeal oedema 11 17
Reintubation 25
Ho 1996
w3 (Taiwan)
Study population Haemodynamic instability, neurological, postoperative, trauma
Time constraint* 24 hours
Mean (SD) age (years) 61 (14) 64 (18)
Sample size (% female) 39 (25.6) 38 (21.1)
Intervention in steroid group 100 mg IV hydrocortisone 1 h before extubation —
Laryngeal oedema 71 0
Reintubation 01
Cheng 2006
w4 (Taiwan)
Study population Medical, surgical
Time constraint* 48 hours
Mean (SD) age (years) 1 injection: 63 (16); 4 injections: 67 (18) 68 (16)
Sample size (% female) 85 (1 injection: n=43 (65.1); 4 injections: n=42 (54.8)) 43 (65.1)
Intervention in steroid group Over 24 h, 40 mg IV infusion methylprednisolone every 6 h
(total 160 mg) in 4 injections group; one infusion of
methylprednisolone followed by three injections of normal
saline every 6 h (total 40 mg) in 1 injection group
—
Laryngeal oedema 5 had 1 injection; 3 had 4 injections 13
Reintubation 2 had 1 injection; 3 had 4 injections 8
Francois 2007
w5 (France and multicentre)
Study population Medical, surgical, and trauma (time constraint 24 h*)
Time constraint* 24 hours
Mean (range) age (years) 65 (46-75) 66 (48-74)
Sample size (% female) 380 (37.0) 381 (35.0)
Intervention in steroid group 20 mg methylprednisolone initiated 12 h before planned
extubation and continued every 4 h with last injection
removal (total 80 mg)
—
Laryngeal oedema 11 76
Reintubation 11 4
Lee 2007
w6 (Taiwan)
Study population Pneumonia, sepsis, heart failure, acute respiratory distress syndrome, COPD (time constraint 48 h*)
Time constraint* 48 hours
Mean (SD) age (years) 72.4 (14.7) 72.7 (13.8)
Sample size (% female) 40 (85.0) 40 (88.0)
Intervention in steroid group 5 mg IV dexamethasone every 6 h, total of four doses with
last injection 24 h before extubation
—
Laryngeal oedema 41 1
Reintubation 12
*Time constraints for investigation after extubation.
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subgroupanalysistoassessthesourceofheterogeneity
and assessed the presence of publication bias visually
with a funnel plot. Differences in risk and number
needed to treat were calculated to assess clinical
significance. In addition, we calculated the power to
confirm the reliability of the analyses.
RESULTS
Trials included
Figure1showsdetailsofstudyidentification,inclusion,
and exclusion. Our search strategy initially yielded
1500citations.Ofthese,weincludedsixuniquestudies
with 1923 participants in this meta-analysis.
w1-w6
Tables 1 and 2 show the characteristics of the
included studies. All trials were undertaken in Eur-
ope
w1 w2 w5 and Asia
w3 w4 w6 in the past 30 years, and
three
w4-w6 were published after 2000. Two trials were
multicentre studies.
w2 w5 Three of them reported
negative results,
w1-w3 and the others reported positive
results.
w4-w6 Most of the included studies were of high
quality(Jadadscore≥3)andclearlyreportedallocation
concealment, except that of Gaussorgues et al (Jadad
score 1), which gave no details of randomisation,
blinding, or allocation concealment.
w1 Intention to
treat analysis was rarely reported.
Allparticipantsinthesixtrialswereadultswhowere
tracheally intubated for at least 24 hours and were
monitored for at least 24 hours after extubation. Two
trials mentioned supportive treatments for laryngeal
oedemaafterextubation,suchasnon-invasivepositive
pressure ventilation (bi-level positive airway pressure)
and the inhalation of racemic adrenaline (epinephri-
ne).
w4 w6 In these studies patients were usually given
intravenous steroidssometimebefore selectedextuba-
tion but the steroids used and doses varied (table 2).
Outcomes for meta-analysis
Table 2 summarises individual study data for the two
outcomes. In the individual studies, most of the
confidence intervals for the odds ratios for laryngeal
oedema and reintubation include 1.0, whereas meta-
analysis indicated that prophylactic steroids before
planned extubation decreased the likelihood of lar-
yngeal oedema after extubation (odds ratio 0.38; 95%
confidence interval 0.17 to 0.85) and subsequent
reintubation (0.29, 0.15 to 0.58) (figs 2 and 3),
corresponding with a risk difference of −0.10 (−0.12
to −0.07; number needed to treat 10) and −0.02 (−0.04
to −0.01; 50), respectively. The Q test, however,
showed statistical heterogeneity in the occurrence of
laryngeal oedema (χ
2=19.48, P=0.002, I
2=74.3%) but
not in the rate of reintubation (χ
2=5.76, P=0.33,
I
2=13.2%). Reanalyses with a random effects model
stillsuggestedthattheregimenreducedtheoccurrence
oflaryngealoedema(0.38,0.17to0.85),corresponding
with a risk difference of −0.10 (−0.20 to 0.00; 10). The
  Cheng 2006w4
  Darmon 1992w2
  Francois 2007w5
  Gaussorgues 1987w1
  Ho 1996w3
  Lee 2007w6
Total (95% CI)
Test for heterogeneity: χ 2=19.48, df=5, P=0.002,
  I2=74.3%
Test for overall effect: z=2.36, P=0.02
0.24 (0.09 to 0.64)
0.66 (0.30 to 1.42)
0.11 (0.06 to 0.22)
2.03 (0.37 to 11.27)
0.61 (0.21 to 1.82)
0.29 (0.08 to 1.02)
0.38 (0.17 to 0.85)
17.47
19.34
20.42
11.33
16.41
15.03
100.00
0.01 0.1 1 10 100
Study
Favours
steroids
Favours
placebo
Odds ratio
(random) (95% CI)
Odds ratio
(random) (95% CI)
8/85
11/327
11/355
4/138
7/39
4/40
45/984
Steroids
13/43
17/337
76/343
2/138
10/38
11/40
129/939
Placebo Weight
(%)
No with laryngeal oedema/
No of intubated patients
Fig 2 | Effect of steroids on laryngeal oedema after extubation
Table 3 |Subgroup and sensitivity analysis of occurrence of laryngeal oedema after extubation and subsequent reintubation
Included trials
Laryngeal oedema Reintubation
No of
studies Steroids Placebo Oddsratio(95%CI) Power
No of
studies Steroids Placebo Oddsratio(95%CI) Power
All studies
w1-w6 6 45/984 129/939 0.38 (0.17 to 0.85)* 1.00 6 11/984 30/939 0.29 (0.15 to 0.58) 0.93
Excluding study with Jadad score
<3
w1
5 41/846 127/801 0.31 (0.14 to 0.67)* 1.00 5 9/846 30/801 0.22 (0.10 to 0.47) 0.97
Excluding study with heaviest
weight
w5
5 34/629 53/596 0.51 (0.32 to 0.80) 0.77 5 10/629 16/596 0.46 (0.21 to 1.00) 0.38
Inclusion of high risk patients
w4 w6 2 12/125 24/83 0.26 (0.12 to 0.56) 0.97 2 6/125 10/83 0.31 (0.11 to 0.90) 0.60
Single dose regimen
Overall
w1-4 4 27/547 42/556 0.61 (0.36 to 1.02) 0.56 4 6/547 14/556 0.45 (0.18 to 1.12) 0.56
Dose equivalent 40 mg†
w1 w2 w4 3 20/508 32/518 0.61 (0.34 to 1.09) 0.50 3 6/508 13/518 0.47 (0.18 to 1.22) 0.48
Dose equivalent 20 mg†
w3 1 7/39 10/38 0.61 (0.21 to 1.82) 0.22 1 0/39 1/38 0.32 (0.01 to 8.01) NA
Multidose regimen
Overall
w4-6 3 18/437 100/426 0.14 (0.08 to 0.23) 1.00 3 5/437 24/426 0.19 (0.07 to 0.50) 0.98
Dose equivalent 160 mg†
w4 1 3/42 13/43 0.18 (0.05 to 0.68) 0.87 1 3/42 8/43 0.34 (0.08 to 1.37) 0.47
Dose equivalent 100 mg†
w6 1 4/40 11/40 0.29 (0.08 to 1.02) 0.58 1 1/40 2/40 0.49 (0.04 to 5.60) 0.14
Dose equivalent 80 mg†
w5 1 11/355 76/343 0.11 (0.06 to 0.22) 1.00 1 1/355 14/343 0.07 (0.01 to 0.51) 0.96
NA=not applicable.
*Adoption of random effects model for significant heterogeneity.
†Dose equivalent to dose of methylprednisolone (mg).
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oedema and reintubation.
Subgroup and sensitivity analysis
Table 3 shows the results of subgroup and sensitivity
analyses. The total incidence of laryngeal oedema after
extubation and subsequent reintubation was 9.0% and
2.1%,whereasinthesubgroupwithamultidoseregimen
the figures were 13.7% and 3.4%. In subgroup analyses
ofdifferentregimens,multipleintravenoussteroidshad
a marked positive effect on the occurrence of laryngeal
oedema (odds ratio 0.14, 0.08 to 0.23) and the rate of
subsequent reintubation (0.19, 0.07 to 0.50), corre-
spondingwithariskdifferenceof−0.19(−0.24to−0.15;
number needed to treat 5) and −0.04 (−0.07 to −0.02;
25), but there was only a trend towards benefit with
single doses (data not shown). We also carried out
subgroup analyses on the relation between dose of
steroid and its effect on laryngeal oedema after
extubation and reintubation. The included trials used
various steroids—such as methylprednisolone, dexa-
methasone, and hydrocortisone. Because of the differ-
ent anti-inflammation effects, we converted all doses of
steroidstotheequivalentdoseofmethylprednisolone.
13
There was no significant difference between doses
equivalent to 20 mg (odds ratio 0.61 for laryngeal
oedema, 0.32 for reintubation) and 40 mg (0.61, 0.47)
methylprednisolone, with all confidence intervals
including 1 in the single dose regimen. In the multiple
doseregimen,however,theeffectofsteroidsequivalent
to 160 mg methylprednisolone (0.18, 0.34) was much
better than that of 100 mg (0.29, 0.49). In addition, the
effect of steroids equivalent to 80 mg methylpredniso-
lone(0.11,0.07)wasthebestcomparedwiththesteroid
doses of 100 mg and 160 mg, but this could have been
becausethatstudydidnotincludehighriskpatientsand
had a large sample size.
w5 Exclusion of the low quality
study
w1 (Jadad score <3) and the heaviest weight trial
w5
did not change the positive direction of our results.
Risk factors associated with development of laryn-
geal oedema after extubation included sex (female),
w5
highacutephysiologicalandchronichealthevaluation
score,
3 low score on the Glasgow coma scale,
w4
excessive endotracheal tube size
14 or patient height/
tube diameter,
w5 and a prolonged intubation period.
w5
Because the presence of an endotracheal tube pre-
cludes direct visualisation of the upper airway,
recognition of the oedema caused by laryngotracheal
injury is often difficult. Upper airway patency, how-
ever,canbeassessedindirectlyinintubatedpatientsby
a cuff leaktest.Areducedcuffleak volumeor cuff leak
volume%oftidalvolumecanpredicttheoccurrenceof
laryngealoedemainpatientswithhighriskfactors.The
use of a cuff leak test before extubation has therefore
been recommended as a screening method for
laryngeal oedema after extubation.
31516 Patients with
a cuff leak volume <110 ml or 24% of tidal volume (a
cut-off point based on the report by Miller and Cole
16)
can be regarded as at high risk. We did subgroup
analysis of high risk patients including two trials.
w4 w6
There were positive effects on the occurrence of
laryngeal oedema (0.26, 0.12 to 0.56) and on the rate
of subsequent reintubation (0.31, 0.11 to 0.90). We
could not carry out a subgroup analysis according to
sex as we did not have the required data.
Adverse events analysis
Three of the studies (n=969) described adverse
events,
w4-w6 but these could not be pooled. In the
steroid group, one patient developed septic shock and
died 26 hours after extubation, and one developed
atelectasis24hoursafterextubation;neithereventwas
considered to be related to the use of steroids. In the
placebo group, one patient developed respiratory
failure and died 23 hours and 15 minutes after
extubation.
DISCUSSION
Principal findings
Airway complications after extubation, especially
reintubation secondary to laryngeal oedema in adults,
are still a problem in intensive care.
17 In our meta-
analysis, the incidence of laryngeal oedema in the
placebo group varied from 3% to 30% and the
reintubation rates from less than 1% to 5%, possibly
because of patients with different risk factors in
individual trials. The routine use of steroids in adults
before planned extubation, which has been done for
decades,
1819 is not yet supported by clinical evidence
with confidence intervals for odds ratios including 1.
Bypoolingdatafromindividualstudiesinasystematic
review,however,wecangainmoretestpowerandadd
precision to the estimates of effect. The present meta-
analysis confirms that, despite various confounding
factors, intravenous steroids do decrease the global
occurrence of laryngeal oedema after extubation by
62%andthesubsequentreintubationby71%.Multiple
dose steroids have a more marked positive effect,
leading to a reduction of laryngeal oedema after
extubation by 86% and the subsequent reintubation
by 81%, but we found no significant differences with
single dose regimens. In such strategies, one event of
laryngeal oedema after extubation or subsequent
reintubation could be avoided by pretreatment with
steroids for 10 or 50 patients, whereas with multidose
  Cheng 2006w4
  Darmon 1992w2
  Francois 2007w5
  Gaussorgues 1987w1
  Ho 1996w3
  Lee 2007w6
Total (95% CI)
Test for heterogeneity: χ 2=5.76, df=5, P=0.33,
  I2=13.2%
Test for overall effect: z=3.49, P<0.001
0.27 (0.08 to 0.90)
0.41 (0.08 to 2.12)
0.07 (0.01 to 0.51)
5.07 (0.24 to 106.65)
0.32 (0.01 to 8.01)
0.49 (0.04 to 5.60)
0.29 (0.15 to 0.58)
30.27
14.82
42.98
1.49
4.54
5.90
100.00
0.01 0.1 1 10 100
Study
Favours
steroids
Favours
placebo
Odds ratio
(fixed) (95% CI)
Odds ratio
(fixed) (95% CI)
5/85
2/327
1/355
2/138
0/39
1/40
11/984
Steroids
8/43
5/337
14/343
0/138
1/38
2/40
30/939
Placebo Weight
(%)
No of resultant reintubation/
No of intubated patients
Fig 3 | Effect of steroids on reintubation after extubation
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patients. We also found a possible dose-effect relation
between steroid dose and its effect on preventing
laryngeal oedema after extubation and reintubation in
the multiple dose regimen. Although steroids have
several potential adverse events, particularly in
patients already at risk of hyperglycaemia and compli-
cationsofinfection,sideeffectswithsteroidtreatments
over 24 hours are minimal.
20 The included studies
found no side effects related to steroids, but adverse
events were not often reported.
Single v multiple dose regimens
Our results confirm the benefit of multidose steroids
before planned extubation of adults. It is difficult to
predict the risk of laryngeal oedema that will require
reintubation. Onset of laryngeal oedema usually occurs
within eight hours after extubation
w1 w2 21 so administra-
tionofsteroidsimmediatelyafterextubationmightbetoo
late. Administration of steroids before selected extuba-
tion is assumed to protect against or treat mucosal
oedema in the glottic region caused by pressure or
irritation from the endotracheal tube. Roberts et al
compared trials published after 2000 with older studies
22
and suggested that the lack of clinical benefit observed
with earlier studies might have resulted from lower total
steroid doses. These authors also pointed out that older
studies generally used only a single dose of steroids and
suggestedthatthis,comparedwiththelongerdurationof
treatmentinnewerstudies,mightaccountforthedifferent
conclusions.Wefoundpossibledosedependenteffectsin
multiple dose regimens but not in single dose regimens.
In multiple dose regimens steroids are usually adminis-
tered at least 12 hours before extubation and repeated
almosteveryplasmahalflife.Thismightmaintainahigh
level of anti-inflammatory activity during the period of
vulnerability to oedema after extubation.
Strengths and limitations
As we included high quality randomised controlled
trials with strong power and obtained relative narrow
confidence intervals, our results are more precise than
those from previous studies.
22 Previous published
systematic reviews focusing on the preventive and
therapeutic effect of steroids in different age groups
showed no clear benefit on the occurrence of airway
complications in adults, but our updated results do
show such a benefit.
4-6
A recent meta-analysis
10 found no clear effect of
steroids on preventing laryngeal oedema after extuba-
tion and reintubation in adults. That study, however,
didnotincludearecenttrialwithpositiveresults.
w6The
addition of this small trial, which was not significant in
its own right, was sufficient to make the results of our
updated meta-analysis significant. The authors of the
previousmeta-analysisalsodidnotdefinereintubation
as major laryngeal oedema needing tracheal reintuba-
tion secondary to upper airway obstruction. This
meant that patients
w2 who needed reintubation during
the follow-up period because of clinical deterioration
ratherthan major laryngealoedema were addedto the
number of reintubations, especially in the steroid
group. The meta-analysis also lacked subgroup ana-
lyses of single versus multidose regimens.
Our study also has some limitations. Few of the
original studies reported intention to treat analyses,
and that reduces the reliability of the data included in
thismeta-analysis.Theuseofsupportivetreatmentsfor
laryngeal oedema after extubation in some of the
included studies might have reduced the apparent
benefit of steroids compared with placebo treatment.
The funnel plot shows asymmetry, so we cannot
eliminate the possibility of publication bias. Sex is an
important risk factor for laryngeal oedema after
extubation and subsequent reintubation, but we
could not do a subgroup analysis because so few trials
reported results separately by sex. Finally, because of
heterogeneity we had to use a random effects model,
which results in wider confidence intervals and thus a
more conservative estimate of treatment effect.
Conclusion
Our meta-analysis of currently available evidence
strongly suggests that prophylactic administration of
parenteral steroids in a multidose regimen before
planned extubation is effective in reducing the global
incidence of laryngeal oedema and subsequent need
forreintubation,withfewadverseevents.Furthertrials
areneededtoestablishtheoptimaldoseofsteroidsand
the optimal time between the start of treatment and
planned extubation.
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